145 related articles for article (PubMed ID: 23346199)
21. Downregulation of miR-144 by triptolide enhanced p85α-PTEN complex formation causing S phase arrest of human nasopharyngeal carcinoma cells.
Wu CW; Wang SG; Lin ML; Chen SS
Eur J Pharmacol; 2019 Jul; 855():137-148. PubMed ID: 31059711
[TBL] [Abstract][Full Text] [Related]
22. Magnolol down-regulates HER2 gene expression, leading to inhibition of HER2-mediated metastatic potential in ovarian cancer cells.
Chuang TC; Hsu SC; Cheng YT; Shao WS; Wu K; Fang GS; Ou CC; Wang V
Cancer Lett; 2011 Dec; 311(1):11-9. PubMed ID: 21757288
[TBL] [Abstract][Full Text] [Related]
23. Inflammatory signaling pathways regulating ApoE gene expression in macrophages.
Gafencu AV; Robciuc MR; Fuior E; Zannis VI; Kardassis D; Simionescu M
J Biol Chem; 2007 Jul; 282(30):21776-85. PubMed ID: 17553793
[TBL] [Abstract][Full Text] [Related]
24. Constitutively active FOXO4 inhibits Akt activity, regulates p27 Kip1 stability, and suppresses HER2-mediated tumorigenicity.
Yang H; Zhao R; Yang HY; Lee MH
Oncogene; 2005 Mar; 24(11):1924-35. PubMed ID: 15688030
[TBL] [Abstract][Full Text] [Related]
25. Triptolide suppresses human synoviocyte MH7A cells mobility and maintains redox balance by inhibiting autophagy.
Xie C; Jiang J; Liu J; Yuan G; Zhao Z
Biomed Pharmacother; 2019 Jul; 115():108911. PubMed ID: 31079001
[TBL] [Abstract][Full Text] [Related]
26. Triptolide Suppresses Alkali Burn-Induced Corneal Angiogenesis Along with a Downregulation of VEGFA and VEGFC Expression.
Wang G; Li N; Lv X; Ahmed N; Li X; Liu H; Ma J; Zhang Y
Anat Rec (Hoboken); 2017 Jul; 300(7):1348-1355. PubMed ID: 28233432
[TBL] [Abstract][Full Text] [Related]
27. Her2 activates NF-kappaB and induces invasion through the canonical pathway involving IKKalpha.
Merkhofer EC; Cogswell P; Baldwin AS
Oncogene; 2010 Feb; 29(8):1238-48. PubMed ID: 19946332
[TBL] [Abstract][Full Text] [Related]
28. Triptolide suppresses interleukin-1beta-induced human beta-defensin-2 mRNA expression through inhibition of transcriptional activation of NF-kappaB in A549 cells.
Jang BC; Lim KJ; Choi IH; Suh MH; Park JG; Mun KC; Bae JH; Shin DH; Suh SI
Int J Mol Med; 2007 May; 19(5):757-63. PubMed ID: 17390080
[TBL] [Abstract][Full Text] [Related]
29. Triptolide exhibits anti-inflammatory, anti-catabolic as well as anabolic effects and suppresses TLR expression and MAPK activity in IL-1β treated human intervertebral disc cells.
Klawitter M; Quero L; Klasen J; Liebscher T; Nerlich A; Boos N; Wuertz K
Eur Spine J; 2012 Aug; 21 Suppl 6(Suppl 6):S850-9. PubMed ID: 21789526
[TBL] [Abstract][Full Text] [Related]
30. EMT-related protein expression in polyploid giant cancer cells and their daughter cells with different passages after triptolide treatment.
Wang X; Zheng M; Fei F; Li C; Du J; Liu K; Li Y; Zhang S
Med Oncol; 2019 Aug; 36(9):82. PubMed ID: 31407170
[TBL] [Abstract][Full Text] [Related]
31. Lapatinib inhibits the activation of NF-κB through reducing phosphorylation of IκB-α in breast cancer cells.
Ma C; Zuo W; Wang X; Wei L; Guo Q; Song X
Oncol Rep; 2013 Feb; 29(2):812-8. PubMed ID: 23229346
[TBL] [Abstract][Full Text] [Related]
32. Cetuximab-Triptolide Conjugate Suppresses the Growth of EGFR-Overexpressing Lung Cancers through Targeting RNA Polymerase II.
Zhang K; Ma Y; Guo Y; Sun T; Wu J; Pangeni RP; Lin M; Li W; Horne D; Raz DJ
Mol Ther Oncolytics; 2020 Sep; 18():304-316. PubMed ID: 32775615
[TBL] [Abstract][Full Text] [Related]
33. Combined Treatment with Triptolide and Tyrosine Kinase Inhibitors Synergistically Enhances Apoptosis in Non-small Cell Lung Cancer H1975 Cells but Not H1299 Cells through EGFR/Akt Pathway.
Tong X; Jiang P; Li Y; Guo L; Zhang HM; Zhang BK; Yan M
Chem Pharm Bull (Tokyo); 2019 Aug; 67(8):864-871. PubMed ID: 31142691
[TBL] [Abstract][Full Text] [Related]
34. Farnesoid X receptor inhibits tamoxifen-resistant MCF-7 breast cancer cell growth through downregulation of HER2 expression.
Giordano C; Catalano S; Panza S; Vizza D; Barone I; Bonofiglio D; Gelsomino L; Rizza P; Fuqua SA; Andò S
Oncogene; 2011 Sep; 30(39):4129-40. PubMed ID: 21499302
[TBL] [Abstract][Full Text] [Related]
35. TPL-2 kinase regulates the proteolysis of the NF-kappaB-inhibitory protein NF-kappaB1 p105.
Belich MP; Salmerón A; Johnston LH; Ley SC
Nature; 1999 Jan; 397(6717):363-8. PubMed ID: 9950430
[TBL] [Abstract][Full Text] [Related]
36. Targets and molecular mechanisms of triptolide in cancer therapy.
Meng C; Zhu H; Song H; Wang Z; Huang G; Li D; Ma Z; Ma J; Qin Q; Sun X; Ma J
Chin J Cancer Res; 2014 Oct; 26(5):622-6. PubMed ID: 25400429
[TBL] [Abstract][Full Text] [Related]
37. Triptolide reduces proliferation and enhances apoptosis in drug-resistant human oral cancer cells.
Tian L; Zhang Y; Wang Y; Dang R; Fu Z; Gu B; Wen N
Int J Clin Exp Pathol; 2019; 12(4):1204-1213. PubMed ID: 31933935
[TBL] [Abstract][Full Text] [Related]
38. Triptolide sensitizes cisplatin-resistant human epithelial ovarian cancer by inhibiting the phosphorylation of AKT.
Huang G; Hu H; Zhang Y; Zhu Y; Liu J; Tan B; Chen T
J Cancer; 2019; 10(13):3012-3020. PubMed ID: 31281478
[TBL] [Abstract][Full Text] [Related]
39. Apigenin induces apoptosis through proteasomal degradation of HER2/neu in HER2/neu-overexpressing breast cancer cells via the phosphatidylinositol 3-kinase/Akt-dependent pathway.
Way TD; Kao MC; Lin JK
J Biol Chem; 2004 Feb; 279(6):4479-89. PubMed ID: 14602723
[TBL] [Abstract][Full Text] [Related]
40. Activation of NF-kappa B by bradykinin through a Galpha(q)- and Gbeta gamma-dependent pathway that involves phosphoinositide 3-kinase and Akt.
Xie P; Browning DD; Hay N; Mackman N; Ye RD
J Biol Chem; 2000 Aug; 275(32):24907-14. PubMed ID: 10801799
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
